1. Home
  2. RDY vs ENVA Comparison

RDY vs ENVA Comparison

Compare RDY & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • ENVA
  • Stock Information
  • Founded
  • RDY 1984
  • ENVA 2011
  • Country
  • RDY India
  • ENVA United States
  • Employees
  • RDY N/A
  • ENVA N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • RDY Health Care
  • ENVA Finance
  • Exchange
  • RDY Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • RDY 2.1B
  • ENVA 2.4B
  • IPO Year
  • RDY N/A
  • ENVA N/A
  • Fundamental
  • Price
  • RDY $14.49
  • ENVA $114.03
  • Analyst Decision
  • RDY Strong Buy
  • ENVA Buy
  • Analyst Count
  • RDY 2
  • ENVA 7
  • Target Price
  • RDY $16.95
  • ENVA $126.33
  • AVG Volume (30 Days)
  • RDY 1.4M
  • ENVA 327.4K
  • Earning Date
  • RDY 07-28-2025
  • ENVA 07-24-2025
  • Dividend Yield
  • RDY 0.56%
  • ENVA N/A
  • EPS Growth
  • RDY 1.47
  • ENVA 52.89
  • EPS
  • RDY 0.79
  • ENVA 8.48
  • Revenue
  • RDY $3,809,801,863.00
  • ENVA $1,304,376,000.00
  • Revenue This Year
  • RDY $10.24
  • ENVA $158.51
  • Revenue Next Year
  • RDY N/A
  • ENVA $12.96
  • P/E Ratio
  • RDY $18.37
  • ENVA $13.44
  • Revenue Growth
  • RDY 16.61
  • ENVA 21.58
  • 52 Week Low
  • RDY $12.26
  • ENVA $71.47
  • 52 Week High
  • RDY $16.89
  • ENVA $119.06
  • Technical
  • Relative Strength Index (RSI)
  • RDY 43.00
  • ENVA 67.08
  • Support Level
  • RDY $14.51
  • ENVA $111.22
  • Resistance Level
  • RDY $14.70
  • ENVA $115.40
  • Average True Range (ATR)
  • RDY 0.16
  • ENVA 2.67
  • MACD
  • RDY -0.06
  • ENVA -0.42
  • Stochastic Oscillator
  • RDY 23.42
  • ENVA 54.79

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: